Taken together, our findings provide new evidence demonstrating that the depleted PGM5‐AS1 competitively binds to miR‐140‐5p, resulting in the decreased expression of FBN1 and suppressed osteosarcoma progression (Fig. 9). Here, PGM5 is linked to osteosarcoma.